.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Merck
McKesson
Chubb
Johnson and Johnson
Chinese Patent Office
Mallinckrodt
Citi
Baxter
Colorcon

Generated: September 21, 2017

DrugPatentWatch Database Preview

AGGRASTAT Drug Profile

« Back to Dashboard

Which patents cover Aggrastat, and when can generic versions of Aggrastat launch?

Aggrastat is a drug marketed by Medicure and is included in two NDAs. There are six patents protecting this drug.

This drug has fifty-nine patent family members in thirty-five countries.

The generic ingredient in AGGRASTAT is tirofiban hydrochloride. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the tirofiban hydrochloride profile page.

Summary for Tradename: AGGRASTAT

Patents:6
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list33
Clinical Trials: see list11
Patent Applications: see list3,584
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AGGRASTAT at DailyMed

Pharmacology for Tradename: AGGRASTAT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medicure
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION020913-001May 14, 1998DISCNNoNo► Subscribe► Subscribe ► Subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION020913-001May 14, 1998DISCNNoNo► Subscribe► Subscribe ► Subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION020912-001May 14, 1998DISCNNoNo► Subscribe► Subscribe ► Subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION020913-002May 17, 2002RXYesNo► Subscribe► Subscribe ► Subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION020913-003Apr 20, 2000RXYesYes► Subscribe► Subscribe ► Subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
SOLUTION;INJECTION020912-002Aug 31, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION020912-001May 14, 1998DISCNNoNo► Subscribe► Subscribe ► Subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
SOLUTION;INJECTION020912-002Aug 31, 2016RXYesYes► Subscribe► Subscribe ► Subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION020913-003Apr 20, 2000RXYesYes► Subscribe► Subscribe ► Subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
SOLUTION;INJECTION020912-002Aug 31, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: AGGRASTAT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medicure
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION020913-002May 17, 2002► Subscribe► Subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
SOLUTION;INJECTION020912-002Aug 31, 2016► Subscribe► Subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION020913-001May 14, 1998► Subscribe► Subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION020913-002May 17, 2002► Subscribe► Subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION020913-002May 17, 2002► Subscribe► Subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION020913-002May 17, 2002► Subscribe► Subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION020912-001May 14, 1998► Subscribe► Subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION020912-001May 14, 1998► Subscribe► Subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION020913-003Apr 20, 2000► Subscribe► Subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION020913-001May 14, 1998► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: AGGRASTAT

Country Document Number Estimated Expiration
China1158107► Subscribe
Malaysia116837► Subscribe
Slovakia282353► Subscribe
Portugal859634► Subscribe
World Intellectual Property Organization (WIPO)03092767► Subscribe
World Intellectual Property Organization (WIPO)9715328► Subscribe
Australia7718996► Subscribe
Canada2318215► Subscribe
Czech Republic290381► Subscribe
Australia2003234596► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: AGGRASTAT

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
/1999Austria► SubscribePRODUCT NAME: TIROFIBAN, GEGEBENENFALLS IN DER FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, INSBESONDERE DES HYDROCHLORIDS; NAT. REGISTRATION NO/DATE: 1-23140 UND 1-23141 19990714; FIRST REGISTRATION: LI IKS-NR 54761 19980528
90040Netherlands► SubscribePRODUCT NAME: TIROFIBAN, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AAN- VAARDBAAR ZOUT OF EEN HYDRAAT, IN HET BIJZONDER TIROFIBANHY- DROCHLORIDE MONOHYDRAAT; NATL REGISTRATION NO/DATE: RVG 23380-1 19990707; FIRST REGISTRATION: DE 42618.00.00-01 19980630
C/GB99/042United Kingdom► SubscribePRODUCT NAME: TIROFIBAN, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, PARTICULARLY THE HYDROCHLORIDE; REGISTERED: LI 54761 19980528; CH 54761 19980528; DE 42618.00.00 19980630; DE 42618.00.01 19980630; DE 42620.00.00 19980630; DE 42620.00.01 19980630; UK PL 00025/0375 19990715; UK PL 00025/0376 19990715
00C/002Belgium► SubscribePRODUCT NAME: TIROFIBANUM HYDROCHLORIDUM (EQ. TIROFIBAN); NAT. REGISTRATION NO/DATE: 922 IS 191 F 12 19990906; FIRST REGISTRATION: CH 54761 19980528
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Harvard Business School
Novartis
US Army
Baxter
Farmers Insurance
Colorcon
Fish and Richardson
McKinsey
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot